European Journal of Clinical Investigation

SJR Rank #3,293H-index: 130SJR: 1.270Best quartile: Q1APC: US$4,100
Journal website: aims, scope and author guidelines
Publisher

John Wiley and Sons Inc

Country

United Kingdom

Type

journal

SJR by Edition

2022202500.350.71.051.4

Subject Categories

  • BiochemistryQ1
  • Clinical BiochemistryQ1
  • Medicine (miscellaneous)Q1

Areas: Biochemistry, Genetics and Molecular Biology · Medicine

Most published research topics

Diabetes, Cardiovascular Risks, and LipoproteinsLipoproteins and Cardiovascular HealthAdipokines, Inflammation, and Metabolic DiseasesLiver Disease Diagnosis and TreatmentCardiovascular Function and Risk FactorsNitric Oxide and Endothelin EffectsDrug Transport and Resistance MechanismsDiet and metabolism studiesAdipose Tissue and MetabolismHeart Failure Treatment and Management

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0200400600800

Documents per Year

20222025055110165220

Detailed Information

ISSN

0014-2972, 1365-2362

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

4.02

References per Document

53.59

Coverage

1970-2026

Scope

EJCI considers any original contribution from the most sophisticated basic molecular sciences to applied clinical and translational research and evidence-based medicine across a broad range of subspecialties. The EJCI publishes reports of high-quality research that pertain to the genetic, molecular, cellular, or physiological basis of human biology and disease, as well as research that addresses prevalence, diagnosis, course, treatment, and prevention of disease. We are primarily interested in studies directly pertinent to humans, but submission of robust in vitro and animal work is also encouraged. Interdisciplinary work and research using innovative methods and combinations of laboratory, clinical, and epidemiological methodologies and techniques is of great interest to the journal. Several categories of manuscripts (for detailed description see below) are considered: editorials, original articles (also including randomized clinical trials, systematic reviews and meta-analyses), reviews (narrative reviews), opinion articles (including debates, perspectives and commentaries); and letters to the Editor.

Metrics from SCImago Journal Rank 2025. View on SCImago